Sulfamethazine sodium is a sulfonamide antibacterial agent used in veterinary medicine; it is applied for the treatment of infections caused by meningococci, pneumococci, hemolytic streptococci, and certain Gram-negative bacilli; it acts by competitively inhibiting bacterial dihydropteroate synthase through structural mimicry of para-aminobenzoic acid (PABA), thereby blocking bacterial folate synthesis and subsequent DNA replication; it also induces CYP3A4 expression and undergoes acetylation via N-acetyltransferase.